The IL-2 receptor (IL-2R) γ chain, the so-called common γ (γ c ) chain, which is shared with multiple cytokine receptors, plays important roles in the immune system. Here we assessed the immunosuppressive ability of mAb specific for the γ c chain in induction of cytotoxic T lymphocytes (CTL) and allograft rejection in combination with mAb specific for the α and β chains of IL-2R. 
Introduction

IL-2 is a T cell cytokine that induces growth differentiation, and activation of various types of hematopoietic cells such as T cells, B cells, NK cells and monocyte/macrophages via interaction with IL-2 receptors (IL-2R) on their surfaces (1).
The IL-2R consists of three distinct subunits, the α (IL-2Rα), β (IL-2Rβ) and γ (IL-2Rγ) chains, and IL-2Rβ and IL-2Rγ are essential for the formation of functional high-and intermediateaffinity receptors (2) . IL-2Rγ, the so-called the common γ (γ c ) chain, is shared as a common subunit among receptors for at least IL-2, IL-4, IL-7, IL-9 and IL-15 (3) . The γ c chain is expressed on almost all of the hematopoietic cell populations in human and mouse (4, 5) , and mutations of the γ c gene cause human X-linked severe combined immunodeficiency characterized by profound depression of T and NK cell development (6, 7) . In mice deficient of the γ c gene, development of mature T and B cells is profoundly suppressed, and NK cells are absent in peripheral lymphoid tissues (8) (9) (10) . Recent reports suggest that signals through the γ c chain Correspondence to: K. Sugamura Transmitting editor: T. Hamaoka Received 25 August 1997, accepted 15 January 1988 contribute to prevention of T cell anergy induced by a defect of co-stimulation through interaction between CD28 and B7 (11) , and regulate activated T cell apoptosis (12) . Moreover, the γ c chain is involved in not only thymocyte development but also maintenance and expansion of peripheral T cells (13) . All the cellular responses through the γ c chain are thought to be related to the immune system. In organ transplantation, T cells in recipients are activated by donor alloantigens to become cytotoxic T lymphocytes (CTL) and T h cells producing a variety of cytokines including IL-2 (14) , and the activated T cells express the inducible IL-2Rα together with IL-2Rβ and γ c chains to be responsive to IL-2 for proliferation and functional activation (1, 3) . Therefore, cytokine-secreting T h cells and cytokine-responsive CTL are prerequisites for allograft rejection (15) . In addition to alloantigen-specific CTL, NK cells also contribute to graft destruction (16) . Not only CTL but also NK cells are known to be responsive to IL-2 for proliferation and functional activation (17, 18) , suggesting that suppression of IL-2 function results in successful transplantation. Indeed, so far, anti-IL-2Rα and anti-IL-2Rβ mAb have been used as effective immunosuppressants in animal experiments (19) (20) (21) (22) (23) and clinical studies (24, 25) , although these agents could not achieve the complete inhibition of graft rejection. We have established mAb specific for the mouse γ c chain, one of which, TUGm2, is able to block cell growth signal transduction mediated by IL-2, IL-4, IL-7, IL-9 and IL-15 (26) (27) (28) (29) . Using TUGm2, we successively achieved a complete inhibition of in vivo CTL induction and a significant suppression of skin allograft rejection in mice.
Methods
Mice
CBA/N (H-2 k ), BALB/c (H-2 d ) and C57BL/6 (H-2 b ) male mice, 6-7 weeks old, were purchased from Japan SLC (Shizuoka, Japan).
mAb
The mAb used were PC615.3 (anti-mouse IL-2Rα, rat IgG1) obtained from ATCC (Rockville, MD), TUm122 (anti-mouse IL-2Rβ, rat IgG2b) (30), TUGm2 (anti-mouse γ c , rat IgG2b ) (26) and REY-7 (anti-HTLV-I gp46, rat IgG2b) (31 CTL induction and cytotoxicity assay P815 (H-2 d ), a mastcytoma cell line derived from DBA/2J mice, EL-4 (H-2 b ), a T lymphoma cell line derived from C57BL/ 6N mice, and B16 (H-2 b ), a melanoma cell line derived from C57BL/6 mice, were used as target cells in 51 Cr-release CTL assays as described previously (32) . To induce CTL, recipient mice were i.p. immunized with 5ϫ10 7 irradiated allogeneic splenocytes, and then i.p. administered with anti-IL-2R mAb or a control mAb on days 0, 2 and 4. On day 5, spleens were removed and the splenocytes were used as effector cells in 51 Cr-release assays. Alternatively, the splenocytes were incubated with irradiated stimulator cells in vitro for 5 days and then used as effector cells in 51 Cr-release assays. Target cells (2ϫ10 6 ) were labeled with 0.1 µCi Na 2 51 CrO 4 (Amersham) at 37°C for 1 h in RPMI 1640 medium containing 10% FCS and washed 3 times with RPMI 1640 medium. 51 Crlabeled target cells (5ϫ10 4 ) were added to serial dilutions of effector cells in a total volume of 200 µl in 96-well roundbottomed microplates, centrifuged to establish cell-cell contact and incubated. After 4 h incubation, the plates were centrifuged and the supernatants were harvested. Radioactivities of the supernatants were counted in a γ-counter. Spontaneous release was Ͻ10% of the maximum release. Results were expressed as follows: % specific lysis ϭ [(release in test -spontaneous release)/(maximum release -spontaneous release)]ϫ100.
Tail skin grafting
Skin grafting was performed on anesthetized recipients as described by Bailey with some modifications (33, 34) . Briefly, a piece of donor tail skin about 0.5 cm 2 and most of the dermis were removed with a scalpel, and transferred onto the side of the recipient tail from which an equivalent area of skin had been removed. Grafts were visually monitored daily. A graft was scored as rejected when 50% of the area of the graft had undergone necrotic degeneration.
Flow cytometry
Immunofluorescence flow cytometric analyses were performed as described elsewhere (5) . mAb used for the flow cytometric analyses were FITC-conjugated anti-CD4 
Statistical analysis
The statistical significance of the mean survival time (MST) for skin graft was assessed by the Mann-Whitney U-test. The significance of the other data was determined by Student's t-test.
Results
Inhibition of MLR by administration of anti-IL-2R mAb
Effects of anti-IL-2R mAb on immune responses were first assessed in allospecific MLR in vitro. Responder and stimulator cells were splenocytes from C57BL/6 (H-2 b ) mice and BALB/c (H-2 d ) mice respectively. Addition of a final concentration of 5 µg/ml of anti-IL-2Rα mAb, PC615.3, into the mixed lymphocyte culture induced a 55% decrease in [ 3 H]thymidine uptake as compared with that of the control mAb, REY-7 ( Fig.  1) . Anti-IL-2 mAb, S4B6, also inhibited the MLR equally well to anti-IL-2Rα mAb (Fig. 1) . In contrast, either anti-IL-2Rβ mAb, TUm122, or anti-γ c mAb, TUGm2, hardly suppressed the MLR at the same concentration as anti-IL-2Rα mAb, although Ͼ10 times higher concentrations of anti-IL-2Rβ and anti-γ c mAb induced obvious suppression of [ 3 H]thymidine uptake in the MLR (data not shown). On the other hand, the combination of anti-IL-2Rβ and anti-γ c mAb significantly blocked [ 3 H]thymidine uptake in the MLR, but the blocking level did not exceed that with anti-IL-2Rα mAb alone (P Ͻ 0.05) (Fig. 1) . Both 60 and 57% reductions in the MLR were obtained with the addition of anti-IL-2Rβ or anti-γ c mAb together with anti-IL-2Rα mAb (P Ͻ 0.05) respectively. Moreover, the combination of the three mAb also showed 60% inhibition of the MLR. These results suggest that anti-IL-2Rα mAb, PC615.3, is capable of suppressing alloantigen-specific MLR, and although anti-IL-2Rβ mAb, TUm122, and anti-γ c mAb, TUGm2, themselves have little suppressive effect on the MLR, they slightly enhance the suppressive effect of anti-IL-2Rα mAb.
Effects of anti-IL-2R mAb on T and NK cell populations in vivo
Prior to examination of in vivo effects of the anti-IL-2R mAb on immune responses, we asked whether in vivo lymphocyte subsets are changed by administration of the mAb. CBA/N (H-2 k ) mice were i.p. immunized with irradiated splenocytes of BALB/c (H-2 d ) mice, and administered i.p. with a final of 300 µg of anti-IL-2R mAb consisting of 100 µg each of anti-IL-2Rα, anti-IL-2Rβ and anti-γ c mAb, or 300 µg of a control mAb, REY-7, on days 0, 2 and 4 after immunization. Their splenocytes were subjected to flow cytometric analyses. All the mice that had received the combination of the three anti-IL-2R mAb or REY-7 were well, with no sign of piloerection, diarrhea or hypomotility during their treatment with the mAb. Numbers of whole splenocytes were slightly higher in mice treated with REY-7 control mAb as compared with mice untreated and treated with the combination of the three anti-IL-2R mAb (data not shown). In spleen, CD4 ϩ CD8 -and CD4 -CD8 ϩ T cells were increased in the mice treated with REY-7 mAb as compared with the mice untreated and treated with the combination of the three mAb (CD4 ϩ CD8 -: 29.4 Ϯ 1.7 versus 26.7 Ϯ 3.8%, P Ͻ 0.005; CD4 -CD8 ϩ : 18.7 Ϯ 1.9 versus 16.7 Ϯ 1.5%, P Ͻ 0.05) (Fig. 2) . NK1.1 ϩ TCRαβ -NK cells were completely depleted in spleens of the mice treated with the three anti-IL-2R mAb, but NK1.1 ϩ TCRαβ ϩ T cells were unaffected (Fig. 2) . On the other hand, T cell subpopulations in thymus were not altered among all the groups of mice (data not shown). Almost all of the cells in spleen and thymus were stained by anti-mouse H-2 k antibody, confirming that allogeneic stimulator cells were eliminated in vivo (data not shown). These results indicate that in vivo administration of REY-7 control mAb results in a slight increase of mature T cell subsets, whereas administration of the three anti-IL-2R mAb does not lead to such an increase.
Effects of anti-IL-2R mAb on induction of allospecific CTL in vivo
Since the addition of anti-IL-2Rβ and anti-γ c mAb induced a slight enhancement of MLR suppression by anti-IL-2Rα mAb, we examined effects of combinations of anti-IL-2R mAb on induction of alloantigen-specific CTL in vivo. CBA/N (H-2 k ) recipient mice were i.p. immunized with irradiated splenocytes of BALB/c (H-2 d ) donor mice, and administered either REY-7 control mAb or combinations of the three anti-IL-2R mAb i.p. on days 0, 2 and 4 after immunization. CTL responses to donor alloantigen were measured 5 days after immunization by a 51 Cr-release assay with P815 (H-2 d ) target cells. There was no statistically significant difference in CTL responses between the mice treated with 300 µg each of REY-7 control mAb and the anti-IL-2Rα mAb, PC615.3 (Fig. 3A) , suggesting that 300 µg of anti-IL-2Rα mAb hardly provides an inhibitory effect on alloantigen-specific CTL induction in vivo. In contrast, the combination of 150 µg each of anti-IL-2Rα and anti-IL-2Rβ mAb significantly inhibited CTL induction as compared with REY-7 control mAb alone or anti-IL-2Rα mAb alone or the combination of 150 µg each of anti-IL-2Rα and anti-γ c mAb (Fig. 3A) . Moreover, administration of 100 µg of anti-γ c mAb together with 100 µg each of anti-IL-2Rα and anti-IL-2Rβ mAb resulted in almost complete suppression of CTL induction (Fig. 3A) . Administration of 300 µg of anti-IL-2Rβ mAb or anti-γ c mAb, or a total of 300 µg mAb containing 150 µg each of anti-IL-2Rβ and anti-γ c mAb showed little suppressive effect on CTL induction (data not shown). Using another allogeneic combination of recipient BALB/c (H-2 d ) mice and donor C57BL/6 (H-2 b ) mice, effects of anti-IL-2R mAb on CTL induction was also examined. The combined administration of the three anti-IL-2R mAb induced the most dramatic suppression of CTL induction, and a significant suppression of CTL induction was induced by the combination of anti-IL-2Rα and anti-IL-2Rβ mAb, but anti-IL-2Rα mAb alone or its combination with anti-γ c mAb showed no effect on CTL induction (Fig. 3B) . The suppressive effect of the combination of the three mAb or anti-IL-2Rα and anti-IL-2Rβ mAb on CTL induction was confirmed to be statistically significant ( Table 1 ). The allospecificities of CTL induced were also confirmed reciprocally with P815 (H-2 d ) and B16 (H-2 b ) (data not shown). These results indicate that simultaneous administration of all the three anti-IL-2R mAb completely inhibits induction of alloantigen specific CTL. Since such CTL induction was little affected by each mAb alone or the combination of the anti-IL-2Rβ and anti-γ c mAb, and partially inhibited by the combination of the anti-IL-2Rα and anti-IL-2Rβ mAb, suggesting an importance of the anti-γ c mAb, TUGm2, for complete suppression of in vivo CTL responses.
Survival prolongation of MHC-incompatible skin allografts in mice treated with anti-IL-2R mAb
Since skin allografts are known to be generally rejected faster than organ allografts, we assessed the in vivo immunosuppressive effect of the three anti-IL-2R mAb in skin allografts. Tail skin grafts of BALB/c mice were transplanted onto tails of recipient CBA/N mice on day 0, and the recipient mice were administered i.p. with a total of 300 µg of mAb in the stipulated combinations of anti-IL-2Rα, anti-IL-2Rβ, anti-γ c and REY-7 control mAb, on days 0, 2, 4, 6 and 8 after transplantation. The recipient mice treated with anti-IL-2Rα mAb or REY-7 control mAb showed 8.6 or 6.4 days MST of skin allografts, while the combination of anti-IL-2Rα and anti-IL-2Rβ mAb prolonged allograft survival up to 11.4 days MST (Fig. 4) . Furthermore, the combination of the three anti-IL-2R mAb, anti-IL-2Rα, anti-IL-2Rβ and anti-γ c mAb, induced more significant prolongation of the skin graft survival up to 22.2 days of MST. These results correlated fairly well with those of CTL induction.
Discussion
The immunosuppressive effects of anti-IL-2Rα and anti-IL-2Rβ mAb have been previously reported in transplantations in humans and mice (20) (21) (22) (23) (24) (25) . Since the fully functional IL-2R includes the γ c chain as an indispensable receptor subunit in addition to IL-2Rα and IL-2Rβ, coupled with the fact that it is shared with receptors for other cytokines such as IL-4, IL-7, IL-9 and IL-15 (3), we hypothesized that anti-γ c mAb contributes to culmination of inhibitory effects of anti-IL-2Rα and anti-IL-2Rβ mAb on IL-2 function, and to suppression of functions of the other cytokines sharing the γ c chain, which would be beneficial to immune suppression. Here we demonstrated that anti-γ c mAb cooperates with anti-IL-2Rα and anti-IL-2Rβ mAb in immune suppression of in vivo alloantigenspecific CTL responses and skin allografts. We first confirmed the suppressive activity of anti-IL-2Rα mAb for MLR representing proliferation of T cells in response to alloantigen in vitro. Although the combination between anti-IL-2Rα mAb and anti-IL-2Rβ mAb or anti-γ c mAb, and combination of the three anti-IL-2R mAb showed slightly enhanced levels of inhibition of MLR in comparison with anti-IL-2Rα mAb alone, either anti-IL-2Rβ or anti-γ c mAb alone had no effect on MLR. These results are consistent with the previous observations that the IL-2R complex consisting of the IL-2Rα, IL-2Rβ and γ c but not the complex consisting of the IL-2Rβ and γ c is functional in the murine system unlike the human system, and thereby anti-IL-2Rα mAb completely blocks IL-2-mediated cell growth, while each of anti-IL-2Rβ or anti-γ c mAb reduces IL-2 binding affinity of the high-affinity IL-2R but is unable to block the T cell growth mediated by IL-2 (26, 30, 35) . Since the IL-2Rα chain is not shared with other cytokine receptors apart from IL-2R, the significant inhibition of MLR by the anti-IL-2Rα mAb alone suggests that IL-2 is a major humoral factor mediating MLR in vitro.
Notwithstanding the significant suppressive activity of anti-IL-2Rα mAb on in vitro MLR, anti-IL-2Rα mAb induced a minimal suppression for in vivo CTL induction similar to anti-IL-2Rβ and anti-γ c mAb, whereas the combination of anti-IL-2Rα and anti-IL-2Rβ mAb but not the combination of anti-IL-2Rα and anti-γ c mAb showed significant inhibition of CTL induction. Furthermore, the combination of the three anti-IL-2R mAb induced almost complete inhibition of CTL response in the combination between recipient CBA/N and donor BALB/ c mice. One may consider why anti-IL-2Rα mAb alone has no suppressive effect on in vivo CTL response, although it induces a powerfull suppressive effect on in vitro MLR. A reason for it may be a difference in circumstances between in vivo and in vitro, affecting dilution, inactivation and degradation of anti-IL-2Rα mAb. We also observed significant suppression of skin allografts by combined administration of anti-IL-2Rα and anti-IL-2Rβ mAb or the three anti-IL-2R mAb, but anti-IL-2Rα mAb alone little induced suppression of skin allografts. However, administration of anti-IL-2Rα mAb alone was previously reported to be significantly effective for suppression of skin allograft rejection in certain strains of mice, but not generally (23) . These observations taken together with our present results suggest that the in vivo immunosuppressive effect of anti-IL-2Rα mAb alone may be influenced by the immunogenetic basis of mouse strains. These results first suggest the possibility that anti-γ c and anti-IL-2Rβ mAb engender significant suppressive activity of anti-IL-2Rα mAb for in vivo IL-2 function which is critically involved in in vivo immune responses such as CTL induction and allograft rejection. However, it has been reported that islet cell allografts can be rejected even in IL-2-deficient mice, suggesting the possible existence of the IL-2-independent mechanism for allograft rejection probably including CTL induction (36) . Hence, it is also possible that anti-γ c and anti-IL-2Rβ mAb contribute to suppression of functions of other cytokines sharing the γ c and IL-2Rβ chains as receptor subunits, which would be involved in in vivo immune responses. It is interesting to learn that IL-4, IL-7, IL-9 and IL-15, all of which interact with the γ c chain, are known to be involved in in vivo development and activation of T and NK cells (37) (38) (39) (40) (41) . Furthermore, the anti-γ c mAb, TUGm2, used here was previously shown to significantly inhibit in vitro functions of IL-4, IL-7, IL-9 and IL-15 (26) (27) (28) (29) . In vivo administration of anti-IL-2Rβ mAb is also known to deplete NK cells (42) , which are considered to be effector cells for allograft rejection together with alloantigen-specific CTL (16) . The present study confirmed the entire depletion of NK1.1 ϩ TCRαβ -NK cells upon treatment of mice with the anti-IL-2R mAb, although T cell subpopulations such as CD4 -CD8 ϩ and CD4 ϩ CD8 -T cells were little affected by in vivo administration of anti-IL-2R mAb. Administration of REY-7 control mAb induced a slight increase of the T cell subpopulations, which may be due to antigenic stimulation with REY-7 mAb, while antigenic stimulation with anti-IL-2R mAb may also be suppressed by themselves. The deletion of NK cells is thought to be derived from functional blocking of IL-2 and IL-15 by anti-IL-2Rβ and anti-γ c mAb, because both the IL-2Rβ and γ c chains are receptor subunits for IL-2 and IL-15 (29) , and not only IL-2 but also IL-15 are known to be involved in development and activation of NK cells (44) (45) (46) . All these observations support the observation that anti-γ c mAb in combination with anti-IL-2Rα and anti-IL-2Rβ mAb is more effective for in vivo immunosuppression than anti-IL-2Rα mAb alone or any other combination of the anti-IL-2R mAb.
